ES2143505T3 - Compuestos de n-arilheteroarilalquil-1-fenil-imidazol-2-ona para el tratamiento de trastornos circulatorios. - Google Patents
Compuestos de n-arilheteroarilalquil-1-fenil-imidazol-2-ona para el tratamiento de trastornos circulatorios.Info
- Publication number
- ES2143505T3 ES2143505T3 ES93914465T ES93914465T ES2143505T3 ES 2143505 T3 ES2143505 T3 ES 2143505T3 ES 93914465 T ES93914465 T ES 93914465T ES 93914465 T ES93914465 T ES 93914465T ES 2143505 T3 ES2143505 T3 ES 2143505T3
- Authority
- ES
- Spain
- Prior art keywords
- phenyl
- treatment
- compounds
- circulatory disorders
- arylheteroarilalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE DESCRIBE UN TIPO DE COMPUESTOS DE 1-FENIL-IMIDAZOL-2-ONAS DE NARILHETEROARILALQUILO A UTILIZAR EN EL TRATAMIENTO DE TRASTORNOS CIRCULATORIOS TALES COMO LA HIPERTENSION Y EL COLAPSO CONGESTIVO. LOS COMPUESTOS DE PARTICULAR INTERES SON ANTAGONISTAS DE LA ANGIOTENSINA II DE LA FORMULA (I) EN LA QUE A SE SELECCIONA DE ENTRE (A), (B), (C), (D), (E) Y (F); EN DONDE M ES UNO; EN DONDE CADA R1, R2 Y R3 SE SELECCIONA, INDEPENDIENTEMENTE, DEL HIBRIDO, ALQUILO, ALCOXI, CIANO, HALO, HIDROXI, CARBOXILO, ALCOXICARBONILO, FORMILO Y ACETILO; ALQUILCARBONILO Y HALOALQUILCARBONILO; EN DONDE R4 ES HIBRIDO; EN DONDE R5 ES ALQUILO; EN DONDE R6 ES UN GRUPO ACIDICO SELECCIONADO DEL COOH Y (G); O UN ESTEREOISOMERO O UN TAUTOMERO DE LOS MISMOS O UN SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96015692A | 1992-10-13 | 1992-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2143505T3 true ES2143505T3 (es) | 2000-05-16 |
Family
ID=25502865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93914465T Expired - Lifetime ES2143505T3 (es) | 1992-10-13 | 1993-06-16 | Compuestos de n-arilheteroarilalquil-1-fenil-imidazol-2-ona para el tratamiento de trastornos circulatorios. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0664802B1 (es) |
JP (1) | JPH08502286A (es) |
AT (1) | ATE190613T1 (es) |
AU (1) | AU4411593A (es) |
CA (1) | CA2143193A1 (es) |
DE (1) | DE69328108D1 (es) |
DK (1) | DK0664802T3 (es) |
ES (1) | ES2143505T3 (es) |
WO (1) | WO1994008990A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780492A (en) * | 1996-04-03 | 1998-07-14 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6093737A (en) * | 1996-12-30 | 2000-07-25 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5939439A (en) * | 1996-12-30 | 1999-08-17 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6127390A (en) * | 1997-10-02 | 2000-10-03 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US7803940B2 (en) | 2006-11-24 | 2010-09-28 | Takeda Pharmaceutical Company Limited | Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0412494A1 (en) * | 1989-08-09 | 1991-02-13 | Bando Chemical Industries, Limited | Master batch for production of toners used in electrophotography |
IL99372A0 (en) * | 1990-09-10 | 1992-08-18 | Ciba Geigy Ag | Azacyclic compounds |
US5210092A (en) * | 1990-09-25 | 1993-05-11 | Fujisawa Pharmaceutical Co., Ltd. | Angiotensin ii antagonizing heterocyclic derivatives |
US5087634A (en) * | 1990-10-31 | 1992-02-11 | G. D. Searle & Co. | N-substituted imidazol-2-one compounds for treatment of circulatory disorders |
US5164403A (en) * | 1991-04-05 | 1992-11-17 | G. D. Searle & Co. | N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders |
-
1993
- 1993-06-16 AT AT93914465T patent/ATE190613T1/de not_active IP Right Cessation
- 1993-06-16 DK DK93914465T patent/DK0664802T3/da active
- 1993-06-16 CA CA002143193A patent/CA2143193A1/en not_active Abandoned
- 1993-06-16 ES ES93914465T patent/ES2143505T3/es not_active Expired - Lifetime
- 1993-06-16 JP JP6509962A patent/JPH08502286A/ja active Pending
- 1993-06-16 WO PCT/US1993/005603 patent/WO1994008990A1/en active IP Right Grant
- 1993-06-16 AU AU44115/93A patent/AU4411593A/en not_active Abandoned
- 1993-06-16 DE DE69328108T patent/DE69328108D1/de not_active Expired - Lifetime
- 1993-06-16 EP EP93914465A patent/EP0664802B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69328108D1 (de) | 2000-04-20 |
EP0664802A1 (en) | 1995-08-02 |
EP0664802B1 (en) | 2000-03-15 |
ATE190613T1 (de) | 2000-04-15 |
JPH08502286A (ja) | 1996-03-12 |
WO1994008990A1 (en) | 1994-04-28 |
CA2143193A1 (en) | 1994-04-28 |
DK0664802T3 (da) | 2000-06-05 |
AU4411593A (en) | 1994-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0863891T3 (da) | (Methylsulfonyl)phenyl-2-(5H)-furanoner som COX2-inhibitorer | |
ATE185797T1 (de) | Stilben-derivate verwendbar als cyclooxygenase-2 hemmer | |
DK0560177T3 (da) | Imidazol-derivater med biphenylsulfonylurinstof- eller biphenylsulfonylurethan-sidekæde, fremgangsmåder til deres fremstilling og deres anvendelse. | |
NO955256L (no) | Fenylheterosykluser som syklooksygenase-2-inhibitorer | |
EA200100412A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
DE69316910D1 (de) | Neue vitamin d derivate | |
DE69130671D1 (de) | 1h-substituierte-1,2,4-triazolverbindungen zur behandlung von herzkrankheiten | |
DE69516503D1 (de) | Piperidinderivate mit paf antagonistischer wirkung | |
ES2143505T3 (es) | Compuestos de n-arilheteroarilalquil-1-fenil-imidazol-2-ona para el tratamiento de trastornos circulatorios. | |
KR960701041A (ko) | 순환장애의 치료를 위한 1-페닐-이미다졸-2-온 비페닐 메틸 화합물(1-phenyl-imidazol-2-one biphenylmethyl compounds for treatmetnt of circulatory disorders) | |
ATE235468T1 (de) | Plättchenaggregationsinhibitoren | |
FI943931A0 (fi) | Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina | |
DK0625155T3 (da) | Pyrroloimidazolyl- og imidazopyridinyl-substituerede 1H-benzimidazolderivater som aromataseinhibitorer | |
EA200300060A1 (ru) | Комбинированная противоопухолевая терапия, включающая применение производных замещенного акрилоилдистамицина и ингибиторов топоизомераз i и ii | |
AR007970A1 (es) | Pirroles sustituidos, su utilizacion y composiciones farmaceuticas que los comprenden | |
MX9303605A (es) | Derivados de azabicicloheptano n-substituidas, su obtencion y uso. | |
EA200300061A1 (ru) | Комбинированная противоопухолевая терапия, включающая применение производных замещенного акрилоилдистамицина и алкилирующих агентов | |
EA200300059A1 (ru) | Комбинированная противоопухолевая терапия, включающая применение производных замещенного акрилоилдистамицина, таксанов и/или антиметаболитов | |
NO940109D0 (no) | Ketorolac-derivater med betydelig redusert gastrointestinal irrit asjon og ulcerasjon | |
ES2101635A1 (es) | Nuevo compuesto derivado del cromeno | |
HUP9902191A2 (hu) | Az érképződést gátló anyag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 664802 Country of ref document: ES |